Radioactive iodine (RAI) does temporarily weaken your immune system, though the effect is usually mild and resolves within a few months. The radiation can damage blood-forming cells in your bone marrow, leading to a dip in white blood cells and other immune markers. For most people, this isn’t severe enough to cause noticeable problems, but it’s worth understanding what happens in your body and how long the changes last.
How RAI Affects Your Bone Marrow
After you swallow the radioactive iodine capsule, most of it concentrates in your thyroid tissue, which is the intended target. But some circulates through your bloodstream and passes through your bone marrow, where your body produces blood cells and immune cells. The radiation damages the DNA of blood-forming stem cells, which can trigger those cells to die off rather than divide normally. This disrupts the production pipeline for white blood cells, the frontline defenders of your immune system.
The degree of bone marrow suppression depends largely on the dose. People treated for Graves’ disease or an overactive thyroid typically receive lower doses than those treated for thyroid cancer. Higher doses mean more radiation exposure to the marrow and a greater chance of measurable immune changes.
Which Immune Cells Are Affected
RAI doesn’t hit every part of your immune system equally. In a study of Graves’ disease patients receiving standard doses, about 14% developed low white blood cell counts (below 3,000 per microliter, compared to a normal range of roughly 4,000 to 11,000) one week after treatment. Notably, neutrophils, the most common type of white blood cell, weren’t significantly reduced in that group, nor were red blood cells or platelets.
For thyroid cancer patients receiving higher doses, the picture is broader. Research tracking specific immune cell populations found that T cells (including helper T cells and killer T cells) and B cells all dropped significantly within the first month after treatment. Specialized immune cells called regulatory T cells, which help prevent your immune system from attacking your own tissues, also declined. These shifts suggest a genuine, temporary suppression of immune function rather than just a dip in one cell type.
How Long the Immune Dip Lasts
The good news is that your immune system bounces back. The timeline, however, is longer than many patients expect. Research following thyroid cancer patients after their first RAI treatment found that immune cell counts hit their lowest point around 30 days post-treatment. By 90 days, most cell types had recovered substantially, but total T cells, B cells, and helper T cells still hadn’t fully returned to their pre-treatment levels.
For lower-dose treatments like those used for Graves’ disease, the recovery tends to be faster. The cases of low white blood cell counts observed at one week were transient, meaning they resolved on their own without intervention. So while the immune suppression is real, it’s self-limiting for the vast majority of patients.
What This Means in Everyday Terms
A temporary dip in immune cell counts doesn’t necessarily mean you’ll get sick. Many people go through RAI treatment without catching any unusual infections. But your body is working with a reduced immune reserve for roughly one to three months, which means your ability to fight off a new infection may be slightly compromised during that window.
Practical steps during this period are straightforward: good hand hygiene, avoiding close contact with people who are actively ill, and staying current on routine health measures. You don’t need to isolate yourself or take extreme precautions the way someone on chemotherapy might.
Timing Vaccines Around Treatment
If you’re planning a vaccination around the same time as RAI therapy, timing matters. Medical guidance from nuclear medicine specialists recommends spacing any vaccine at least two weeks before your RAI dose if there’s concern about the treatment causing enough immune suppression to blunt your vaccine response. That said, RAI for thyroid disease doesn’t appear to fundamentally interfere with the immune system’s ability to respond to vaccines. The key recommendation is to avoid delaying your RAI treatment unnecessarily. Talk with your care team about scheduling so both your treatment and any planned vaccinations land at the right time.
Repeated Treatments and Cumulative Effects
Some thyroid cancer patients require more than one round of RAI. Each treatment delivers another dose of radiation to the bone marrow, and the cumulative exposure raises the stakes. Severe bone marrow suppression is rare after a single treatment, but the risk increases with repeated or very high doses. Your medical team will monitor your blood counts before and after treatment to watch for this, particularly if you need multiple rounds.
For people treated once at standard doses, whether for hyperthyroidism or thyroid cancer, lasting immune damage is uncommon. The bone marrow recovers its function, and long-term immune health isn’t typically affected.